Relmada Therapeutics to Participate in the Goldman Sachs Global Healthcare Conference : vimarsana.com

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Related Keywords

Sergio Traversa , Cedric Ogorman , Maged Shenouda , Tim Mccarthy , Securities Exchange , Goldman Sachs , Nasdaq , Prnewswire Relmada Therapeutics Inc , Reliance Clinical Research Program , Relmada Therapeutics Inc , Chief Executive Officer , Chief Financial Officer , Cedrico Gorman , Chief Medical Officer , Goldman Sachs Global Healthcare Conference , Dana Point , Relmada Therapeutics , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Nc ,